Abstract
In the EXCEL trial, PCI with everolimus-eluting stents was non-inferior to CABG at 3 years for treatment of left main coronary artery disease (LMCAD) with low or intermediate SYNTAX scores. We sought to assess whether chronic obstructive pulmonary disease (COPD), an independent risk factor for worse
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
